Internal Medicine · San Juan, PR
NPI
1538262183
Since 2006
Specialty
Internal Medicine
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
923 Ave Campo Rico, Country Club
San Juan, PR, 00924
Phone (787) 750-0444
Medicare paid, 2024
$2,250
42 services
Medicare patients, 2024
13
Average age 75
Drug cost, 2024
$1.0M
16,116 prescriptions
Company payments, 2025
$339
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos R Gonzalez Fuentes was code 99213 (office e&m - established), 41 times for 13 patients. In total Carlos R Gonzalez Fuentes billed 42 services in 2 codes, and Medicare paid $2,250.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-03-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 41 | 13 | $53.63 | $2,199 |
By year: 2022 $3,279 for 70 services; 2023 $3,788 for 70 services; 2024 $2,250 for 42 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos R Gonzalez Fuentes prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,005 prescriptions and refills. In total Carlos R Gonzalez Fuentes wrote 16,116 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,005 | 2,926 | 328 | $14K |
| Losartan Potassium Generic | 934 | 2,710 | 287 | $14K |
| Rosuvastatin Calcium Generic | 830 | 2,431 | 279 | $15K |
| Amlodipine Besylate Generic | 821 | 2,411 | 271 | $6,052 |
| Gabapentin Generic | 594 | 1,533 | 186 | $8,188 |
| Metformin Hcl Generic | 510 | 1,433 | 155 | $3,822 |
| Synthroid Levothyroxine Sodium | 467 | 1,216 | 129 | $52K |
| Metoprolol Succinate Generic | 436 | 1,255 | 137 | $9,757 |
| Levothyroxine Sodium Generic | 395 | 1,124 | 117 | $6,767 |
| Clonazepam Generic | 375 | 379 | 85 | $3,077 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 357 | 1,053 | 113 | $8,239 |
| Famotidine Generic | 329 | 484 | 98 | $2,744 |
| Pantoprazole Sodium Generic | 251 | 361 | 55 | $2,537 |
| Omeprazole Generic | 225 | 319 | 56 | $1,469 |
| Doxazosin Mesylate Generic | 221 | 653 | 69 | $6,933 |
Brand drugs: 1,793 claims; generic drugs: 14,243 claims; opioid claims: 82.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos R Gonzalez Fuentes $339 ($339 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $289.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 4 | $289 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.